SMART MDI THERAPY

For people who manage their diabetes with insulin injections, Smart MDI (multiple daily injections) therapy is intended to relieve the physical and mental effort required to manage diabetes, by using an ecosystem of smart-enabled technology to increase patient compliance and adherence.

The virtual booth may include information on products and therapies, and safe and effective uses of those products and therapies, which may not necessarily be approved in accordance with the laws in all countries. Accordingly, attendees must review applicable product labelling for their country for indications and instructions prior to use.

InPen™ with integrated Guardian™ Connect system

The Guardian™ Connect smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance — helping people on multiple daily injections stay ahead of highs and lows. The InPen™ system is the first and only FDA-cleared smart insulin pen system designed to help people living with insulin-dependent diabetes know the right amount of insulin to take, at the right time. Together the systems help people on multiple daily injections spend less time managing the math of diabetes and more time doing the things they want.

What is the value of Smart MDI therapy? A patient's perspective. - (02:48)

Lifestyle and other factors can influence the right therapy choice, hear directly from Sarah about her journey to Smart MDI therapy.
More information (see more) Less information (see less)

pdf InPen™ Patient Insert (.pdf)

Guess less. Live more. Now with real-time CGM data.

860KB

*

Smart insulin pens connect to a mobile app to provide dosing calculations, reminders and CGM system integration.

Important Safety Information for Guardian™ Connect system:
For continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. Rx Only. Proper mobile device, settings required. See http://bit.ly/GCRisks

Important Safety Information: InPen™:
The InPen™ is a home-use reusable pen injector for single-patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self-injection of a desired dose of insulin and for calculating an insulin dose or carbohydrate intake based on user entered data. A healthcare professional must assist in dosage programming of the device prior to use, based on various patient-specific criteria and targets. The InPen™ requires a prescription. For additional product and safety information, please consult the Instructions for Use and bit.ly/InPenSafety.

inpen-guardian-app-iphone

Guardian™ Connect system

The Guardian™ Connect smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance - helping people on multiple daily injections stay ahead of highs and lows.

pdf Guardian™ Connect CGM HCP Brochure (.pdf)

Intelligence at your patients’ fingers so that they feel in control.

1.2MB

*

Important Safety Information for Guardian™ Connect system: 
For continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. Rx only. Proper mobile device, settings required. See http://bit.ly/GCRisks.

User interaction required. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.

Product image of the i-Port Advance on white background

i-PORT ADVANCE™ INJECTION PORT

The i-Port Advance™ injection port allows individuals to inject their medications without puncturing their skin every time. The i-Port Advance injection port is the first device to combine a port and an inserter in one complete set. Now with one click of the inserter, the injection port is easily applied to provide a simple and convenient way to take multiple injections without having to puncture the skin for each dose.

pdf i-Port Advance™ Injection Port HCP Brochure  (.pdf)

Reasons to prescribe i-Port Advance injection port for your patients.

289KB

*

Important Safety Information for i-PORT™ ADVANCE i-Port™ Advance Injection Port:
For patients who administer or receive multiple daily subcutaneous injections of physician prescribed medications, including insulin. The device may remain in place for up to 72 hours. Rx Only. For details, see manual.

   

image
CONTACT

Do you have any questions? We’d like to hear from you.

Contact us